ROSALEEN LIM: Open Payments
NPI 1578206389 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 17 payments from 8 companies in 2025. Trend: 2023 $930 · 2024 $407 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Edwards Lifesciences Corporation | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Boston Scientific Corporation | 1 | $29 |
| Medtronic, Inc. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $14 |
Products named: JARDIANCE, LEQVIO, FARXIGA, SHINGRIX, WAINUA, WATCHMAN Access System, SAPIEN 3 Ultra RESILIA, COREVALVE EVOLUT R.
Industry payments across IL — which companies pay providers there.
